Collectively, these computational findings highlight coordinated complement-coagulation dysregulation, humoral immune remodeling, and TFRC-associated iron-related immune alterations in severe COVID-19, and prioritize TFRC, C9, and LBP as candidate molecular indicators requiring further experimental and clinical validation. Here, C9 is linked to COVID-19.